Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Innoviva (INVA) over the last 16 years, with Sep 2025 value amounting to $10.8 million.

  • Innoviva's Cash from Financing Activities rose 177.30% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 million, marking a year-over-year increase of 99.05%. This contributed to the annual value of -$13.5 million for FY2024, which is 92.17% up from last year.
  • Latest data reveals that Innoviva reported Cash from Financing Activities of $10.8 million as of Q3 2025, which was up 769.45% from $1.2 million recorded in Q2 2025.
  • Innoviva's 5-year Cash from Financing Activities high stood at $60.3 million for Q1 2022, and its period low was -$440.4 million during Q3 2021.
  • Its 3-year average for Cash from Financing Activities is -$35.5 million, with a median of -$9.2 million in 2024.
  • As far as peak fluctuations go, Innoviva's Cash from Financing Activities tumbled by 3,670,158.33% in 2021, and later soared by 383.11% in 2022.
  • Quarterly analysis of 5 years shows Innoviva's Cash from Financing Activities stood at -$440.4 million in 2021, then spiked by 89.65% to -$45.6 million in 2022, then tumbled by 245.10% to -$157.2 million in 2023, then surged by 91.08% to -$14.0 million in 2024, then surged by 177.30% to $10.8 million in 2025.
  • Its Cash from Financing Activities was $10.8 million in Q3 2025, compared to $1.2 million in Q2 2025 and $183,000 in Q1 2025.